Position in IBRX
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$7,670
+$5,690 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CENTRAL TRUST Co holds $4,183,405 across 25 Biotechnology names. IBRX ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,963 | $3,109,257 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,075 | $830,588 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
742 | $140,275 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
448 | $28,954 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
112 | $22,360 | |
| 6 | EXEL |
Exelixis, Inc.
|
300 | $12,867 | |
| 7 | RPRX |
Royalty Pharma plc
|
242 | $11,608 | |
| 8 | IBRX |
ImmunityBio, Inc.
This page
|
1,000 | $7,670 |
All Filings in IBRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,670 | 1,000 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,980 | 1,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,460 | 1,000 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,640 | 1,000 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,010 | 1,000 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $2,560 | 1,000 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,720 | 1,000 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $6,320 | 1,000 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $5,370 | 1,000 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $5,020 | 1,000 | Shares | Sole | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||